Lifecore Biomedical Inc. (LFCR) stock news · $207.1M cap
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This LFCR news page leads with what Lifecore Biomedical Inc. filed — not a scraped headline mill.
No cached 8-K sentence for LFCR yet. We will not pad this page with generic market recap.
Latest reported LFCR revenue for 2026-06-30 was $34.2M. Net income was -$6.2M. Revenue was up 47.3% from 2026-03-31 to 2026-06-30. LFCR currently screens at market cap $207.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LFCR stock page; for the tape open the quote page.
LFCR stock news FAQ
What are LFCR's latest revenue and net income?
Latest cached Lifecore Biomedical Inc. (LFCR) revenue for Jun 30, 2026 was $34.2M. Net income was -$6.2M. Statements: https://lician.com/financials/lfcr
How did LFCR revenue change from the prior cached period?
Cached Lifecore Biomedical Inc. (LFCR) revenue was up 47.3% from $23.2M (Mar 31, 2026) to $34.2M (Jun 30, 2026). Statements: https://lician.com/financials/lfcr
What is LFCR's market cap?
Lifecore Biomedical Inc. (LFCR) market cap is $207.1M on the latest cached fundamentals snapshot.
What kind of company is LFCR?
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is LFCR stock news listed?
Cached stock news for Lifecore Biomedical Inc. (LFCR) is listed at https://lician.com/news/lfcr. Filings: https://lician.com/sec/lfcr
Not investment advice.